TuisBBN • SWX
Bellevue Group AG
CHF 14,50
15 Jan., 06:10:02 GMT+1 · CHF · SWX · Vrywaring
AandeelCH-gelyste effek
Vorige sluiting
CHF 14,75
Dagwisseling
CHF 14,50 - CHF 14,80
Jaarwisseling
CHF 11,05 - CHF 24,30
Markkapitalisasie
195,19 m CHF
Gemiddelde volume
9,95 k
P/V-verhouding
13,08
Dividend-opbrengs
7,93%
Primêre beurs
SWX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(CHF)Jun. 2024J/J-verandering
Inkomste
18,41 m-11,31%
Bedryfskoste
13,73 m-10,56%
Netto inkomste
3,72 m-7,22%
Netto winsgrens
20,184,61%
Wins per aandeel
EBITDA
Effektiewe belastingkoers
17,26%
Totale bates
Totale aanspreeklikheid
(CHF)Jun. 2024J/J-verandering
Kontant en korttermynbeleggings
30,49 m100,63%
Totale bates
138,75 m-4,69%
Totale aanspreeklikheid
22,05 m-24,81%
Totale ekwiteit
116,70 m
Uitstaande aandele
13,20 m
Prys om te bespreek
1,67
Opbrengs op bates
10,71%
Opbrengs op kapitaal
Netto kontantverandering
(CHF)Jun. 2024J/J-verandering
Netto inkomste
3,72 m-7,22%
Kontant van bedrywe
3,65 m137,31%
Kontant van beleggings
Kontant van finansiering
-8,10 m45,85%
Netto kontantverandering
-4,17 m83,13%
Beskikbare kontantvloei
Meer oor
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021. Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Gestig
1993
Werknemers
88
Search
Vee soektog uit
Maak soekkassie toe
Google-programme
Hoofkieslys